课题基金 / 基金详情

CANada in the INCremental dialysis to improve Health outcomes in people starting Hemodialysis (CAN INCH-HD) study: a randomized controlled trial

CANada in the INCremental dialysis to improve Health outcomes in people starting Hemodialysis (CAN INCH-HD) study: a randomized controlled trial
加拿大开展增量透析以改善开始血液透析患者的健康结果 (CAN INCH-HD) 研究：一项随机对照试验
批准号：
452633
负责人：
Lok Charmaine E
金额：
$47.65万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-09-01 至 2026-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452633&lang=en
关键词：
Dialysis Initiation Frequency Of Dialysis Health Economics Kidney Failure Patient Engagement Quality Of Life Safety

项目摘要

项目成果

Lok Charmaine E的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most patients in the developed world with kidney failure start dialysis with thrice weekly hemodialysis (HD). Although the most common treatment for kidney failure, HD continues to be associated with drastically reduced quality of life (QoL <60% of full h
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Best Extremity Survival Times And Concurrent Complications:Examination of Secondary Access Study (BEST ACCESS): Pilot Study
  • 批准号：
    182314
  • 项目类别：
    Randomized Controlled Trials
  • 资助金额：
    $13.12万
  • 财政年份：
    2009
  • 负责人：
    Lok Charmaine E
  • 依托单位：
    Toronto General Hospital